{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:55:18Z","timestamp":1791330918823,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Structural Biology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jsb.2006.08.015","type":"journal-article","created":{"date-parts":[[2006,9,10]],"date-time":"2006-09-10T07:09:41Z","timestamp":1157872181000},"page":"348-355","source":"Crossref","is-referenced-by-count":214,"title":["Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin"],"prefix":"10.1016","volume":"157","author":[{"given":"Feng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbing","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsb.2006.08.015_bib1","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1074\/jbc.M410973200","article-title":"Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity","volume":"280","author":"Ahmed","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib2","doi-asserted-by":"crossref","first-page":"38731","DOI":"10.1074\/jbc.M005460200","article-title":"Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures","volume":"275","author":"Bhattacharya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1006\/jmbi.2000.4158","article-title":"Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin","volume":"303","author":"Bhattacharya","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsb.2006.08.015_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0049-3848(81)90205-X","article-title":"Acetylation of albumin by low doses of aspirin","volume":"23","author":"Burch","year":"1981","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jsb.2006.08.015_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsb.2006.08.015_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jsb.2006.08.015_bib7","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm010960b","article-title":"models to predict binding affinities to human serum albumin","volume":"44","author":"Colmenarejo","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jsb.2006.08.015_bib9","series-title":"The PyMol Molecular Graphics System","author":"DeLano","year":"2004"},{"key":"10.1016\/j.jsb.2006.08.015_bib10","first-page":"647","article-title":"Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide","volume":"47","author":"Dubois-Presle","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsb.2006.08.015_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jsb.2006.08.015_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsb.2006.08.015_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbagen.2005.11.018","article-title":"Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases","volume":"1760","author":"Gresner","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsb.2006.08.015_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/jm00209a001","article-title":"Novel analgesic-antiinflammatory salicylates","volume":"21","author":"Hannah","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI106011","article-title":"Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid","volume":"48","author":"Hawkins","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsb.2006.08.015_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1126\/science.160.3829.780","article-title":"Acetylation of human serum albumin by acetylsalicylic acid","volume":"160","author":"Hawkins","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.jsb.2006.08.015_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2006.08.015_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0161-5890(91)90093-Y","article-title":"Acetylsalicylate\u2013human serum albumin interaction as studied by NMR spectroscopy-antigenicity-producing mechanism of acetylsalicylic acid","volume":"28","author":"Honma","year":"1991","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jsb.2006.08.015_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1248\/yakushi1947.106.10_841","article-title":"Enzymatic activity and drug binding activity of human serum albumin","volume":"106","author":"Ikeda","year":"1986","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jsb.2006.08.015_bib20","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1248\/cpb.33.4995","article-title":"Esterase-like activity of human serum albumin: V. Reaction with 2,4-dinitrophenyl diethyl phosphate","volume":"33","author":"Yoshida","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsb.2006.08.015_bib21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsb.2006.08.015_bib22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1248\/cpb.40.2169","article-title":"Esterase-like activity of human serum albumin. VIII. Reaction with amino acid p-nitrophenyl esters","volume":"40","author":"Kurono","year":"1992","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jsb.2006.08.015_bib23","doi-asserted-by":"crossref","first-page":"42924","DOI":"10.1074\/jbc.M406957200","article-title":"Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin","volume":"279","author":"Lejon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib24","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1016\/S0021-9258(18)37442-8","article-title":"Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin complexes with bilirubin and its esters","volume":"263","author":"Lighnter","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2006.08.015_bib25","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1021\/bi00693a031","article-title":"Acetylation of human serum albumin by p-nitrophenyl acetate","volume":"14","author":"Means","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsb.2006.08.015_bib26","first-page":"299","article-title":"Human antibodies against acetylsalicylic acid-altered human serum albumin","volume":"10","author":"Minden","year":"1967","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jsb.2006.08.015_bib27","series-title":"All About Albumin: Biochemistry, Genetics and Medical Applications","author":"Peters","year":"1995"},{"key":"10.1016\/j.jsb.2006.08.015_bib28","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1073\/pnas.1137188100","article-title":"Structural basis of albumin\u2013thyroxine interactions and familial dysalbuminemic hyperthyroxinemia","volume":"100","author":"Petitpas","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsb.2006.08.015_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/219068a0","article-title":"In vitro acetylation of plasma proteins, enzymes and DNA by aspirin","volume":"219","author":"Pinckard","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2006.08.015_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00000441-196609000-00003","article-title":"Salicylates and bleeding: the aspirin tolerance test","volume":"252","author":"Quike","year":"1966","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jsb.2006.08.015_bib31","first-page":"i 386","article-title":"Aspirin and platelet stickness","author":"Quike","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jsb.2006.08.015_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/B:PHAM.0000016241.84630.06","article-title":"Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jsb.2006.08.015_bib33","first-page":"395","article-title":"Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid","volume":"25","author":"Salvi","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsb.2006.08.015_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0021-8707(67)90076-7","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J. Allergy"},{"key":"10.1016\/j.jsb.2006.08.015_bib35","first-page":"824","article-title":"The characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsb.2006.08.015_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/protein\/12.6.439","article-title":"Crystal structure of human serum albumin at 2.5A resolution","volume":"12","author":"Sugio","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.jsb.2006.08.015_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/189147a0","article-title":"Anticomplementary action of aspirin","volume":"189","author":"van","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2006.08.015_bib38","series-title":"Aspirin and Other Salicylates","author":"Vane","year":"1992"},{"key":"10.1016\/j.jsb.2006.08.015_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-5793(76)80496-6","article-title":"Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid","volume":"66","author":"Walker","year":"1976","journal-title":"FEBS Lett."},{"issue":"Pt 3","key":"10.1016\/j.jsb.2006.08.015_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/bj3490813","article-title":"Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity","volume":"349","author":"Watanabe","year":"2000","journal-title":"Biochem. J."}],"container-title":["Journal of Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847706002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847706002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T01:49:03Z","timestamp":1627782543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047847706002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1047847706002796"],"URL":"https:\/\/doi.org\/10.1016\/j.jsb.2006.08.015","relation":{},"ISSN":["1047-8477"],"issn-type":[{"value":"1047-8477","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}